Skip Navigation

Publication Detail

Title: ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.

Authors: Wang, Lidong; Yang, Huibin; Palmbos, Phillip L; Ney, Gina; Detzler, Taylor Ann; Coleman, Dawn; Leflein, Jacob; Davis, Mary; Zhang, Min; Tang, Wenhua; Hicks, J Kevin; Helchowski, Corey M; Prasad, Jayendra; Lawrence, Theodore S; Xu, Liang; Yu, Xiaochun; Canman, Christine E; Ljungman, Mats; Simeone, Diane M

Published In Cancer Res, (2014 Mar 15)

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is characterized by therapeutic resistance for which the basis is poorly understood. Here, we report that the DNA and p53-binding protein ATDC/TRIM29, which is highly expressed in PDAC, plays a critical role in DNA damage signaling and radioresistance in pancreatic cancer cells. Ataxia-telangiectasia group D-associated gene (ATDC) mediated resistance to ionizing radiation in vitro and in vivo in mouse xenograft assays. ATDC was phosphorylated directly by MAPKAP kinase 2 (MK2) at Ser550 in an ATM-dependent manner. Phosphorylation at Ser-550 by MK2 was required for the radioprotective function of ATDC. Our results identify a DNA repair pathway leading from MK2 and ATM to ATDC, suggesting its candidacy as a therapeutic target to radiosensitize PDAC and improve the efficacy of DNA-damaging treatment.

PubMed ID: 24469230 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top